Status of Overseas and Domestic sales | |
---|---|
A Japanese importer of
veterinary equipment learned about Anyfusion performance through the internet
and offered 10 Anyfusion V100s and 15 cartridges. Japan is home to two of the
world's largest pump companies, Terumo and Nipro. More than 70% of major
university hospitals in Korea use Terumo products. The reason why we offered
our product despite the presence of world-class drug infusion pumps is because
of Anyfusion's real-time 0% accuracy, which is impossible for Japanese
companies, as well as American and German companies. The U.S. Department of Veterans Affairs hospitals, which provide the best care and treatment for our nation's veterans, seek to serve them with the most advanced medical devices in the world. Infusion pumps are the market Anyfusion is targeting with its best-fit technology. This will be a bridgehead to expanding to hospital use across the US. With the cooperation of a few people, we have started FDA510K certification. Anyfusion has been granted STeP priority review as a breakthrough medical device, which means it will be reviewed on the fast track, and we expect to receive certification within a few months. As soon as possible after FDA 510K certification, we will register with the U.S. Government Procurement Service to be used in Veterans Affairs hospitals. Registration with the U.S. Government Procurement Service will enable Anyfusion to be used in public hospitals, including Veterans Affairs hospitals, and in the procurement market for ambulances, ambulance helicopters, and spacecraft drug infusion pumps. The European public procurement market, which has a high level of medical welfare, will also eventually become an Anyfusion market. In Korea, it will be selected for the public procurement priority purchase system and become a reference for entering the global public procurement market. A premature baby (low weight baby) admitted to the neonatal intensive care unit of Nowon Hospital, U University, was unable to raise various levels to normal with a conventional pump, and the professor in charge urgently requested Anyfusion, and as a result, various levels were normal from the next day, and the baby was discharged as a normal baby after about 40 days. At the request of the professor, the code was registered and started to be used within 10 days of the emergency purchase. In addition, the high performance of Anyfusion was verified at the regional trauma center of G Hospital, Incheon, G University, and it was decided to prescribe it. It will be a good reference for the neonatal intensive care unit and regional trauma center of G University Hospital. Thank you. |
Next | Necessity of medical care benefit and price adjustment |
---|---|
Prev | Anyfusion ACPi system, Daegu K University Hospital and Italy G Company Milan University Hospital |